Molecular biology of K+ channels and their role in cardiac arrhythmias

American Journal of Medicine

Volumn 110, Issue 1, 2001, Pages 50-59

  Tristani Firouzi, Martin ^a   Chen, Jun ^a   Mitcheson, John S ^a   Sanguinetti, Michael C ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ADENOSINE TRIPHOSPHATE; AMANTADINE; AMIODARONE; AMITRIPTYLINE; ANTIARRHYTHMIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIMIGRAINE AGENT; ASTEMIZOLE; BEPRIDIL; CALCIUM CHANNEL BLOCKING AGENT; CEREBRYX; CHLOROQUINE; CHLORPROMAZINE; CISAPRIDE; CLARITHROMYCIN; CLEMASTINE FUMARATE; COTRIMOXAZOLE; DESIPRAMINE; DIPHENHYDRAMINE; DISOPYRAMIDE; DISOPYRAMIDE PHOSPHATE; DOFETILIDE; DOXEPIN; DROPERIDOL; ERYTHROMYCIN; FELBAMATE; FLECAINIDE; FLECAINIDE ACETATE; FLUCONAZOLE; FLUOXETINE; FOSCARNET SODIUM; FOSPHENYTOIN SODIUM; GREPAFLOXACIN; HALOFANTRINE; HALOPERIDOL; IBUTILIDE FUMARATE; IMETREX; IMIPRAMINE; INDAPAMIDE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE; MOXIFLOXACIN; NARATRIPTAN; NEUROLEPTIC AGENT; NICARDIPINE; PENTAMIDINE; PENTAMIDINE ISETHIONATE; PIMOZIDE; POTASSIUM; POTASSIUM CHANNEL; PROBUCOL; PROCAINAMIDE; QUINIDINE; RISPERIDONE; SOTALOL; SPARFLOXACIN; SUMATRIPTAN; TACROLIMUS; TAMOXIFEN CITRATE; TERFENADINE; THIORIDAZINE; UNCLASSIFIED DRUG; VENLAFAXINE; ZOLMITRIPTAN;

ARRHYTHMOGENESIS; CHANNEL GATING; GENE MUTATION; HEART ARRHYTHMIA; HEART MUSCLE POTENTIAL; HUMAN; LIGAND BINDING; LONG QT SYNDROME; MOLECULAR BIOLOGY; POTASSIUM CURRENT; PRIORITY JOURNAL; REVIEW; TORSADE DES POINTES;

ANIMALS; ARRHYTHMIA; HEART CONDUCTION SYSTEM; HUMANS; LONG QT SYNDROME; MUTATION; POTASSIUM CHANNELS; TACHYCARDIA, VENTRICULAR; TORSADES DE POINTES;

EID: 0035180746     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(00)00623-9     Document Type: Review

References (71)

1. Cloning of genomic and complementary DNA from Shaker, a putative potassium channel gene from Drosophila
2. Determination of the subunit stoichiometry of a voltage-activated potassium channel
3. Nomenclature of mammalian voltage-dependent potassium channel genes
4. Inward rectifier potassium channels
5. + channels
6. + channel diversity in the mammalian myocardium
7. + channel in ventricular muscle (a molecular correlate for the transient outward current)
8. Voltage gating of ion channels
9. The moving parts of voltage-gated ion channels
10. + current: Differential sensitivity to block by class III antiarrhythmic agents
11. IK is comprised of two components in guinea pig atrial cells
12. A quantitative description of the E-4031-sensitive repolarization current in rabbit ventricular myocytes
13. Ks contributes to the longer action potential of the M cell
14. Ks play a role in the reverse rate dependence of class III agents?)
15. + channels in atrial cells of guinea pig heart
16. Characterization of an ultrarapid delayed rectifier potassium channel involved in canine atrial repolarization
17. + channel current
18. Three types of delayed rectifier potassium currents in human atrial cardiomyocytes
19. + channels of cardiac muscle
20. sK channels by the chromanol 293B
21. Kr channel
22. + current in cultured adult human atrial myocytes
23. Kr potassium channel
24. HERG, a human inward rectifier in the voltage-gated potassium channel family
25. Kr potassium channels with HERG, and is associated with cardiac arrhythmia
26. Ks cardiac potassium channel
27. Ks potassium channel
28. + current
29. + channel in mouse and human hearts
30. + channel splice variant common in human heart lacks a C-terminal domain required for expression of rapidly activating delayed rectifier current
31. Attenuation of the slow component of delayed rectification, action potential prolongation, and triggered activity in mice expressing a dominant-negative Kv2 alpha subunit
32. Potassium channel block by cytoplasmic polyamines as the mechanism of intrinsic rectification
33. The mechanism of inward rectification of potassium channels: "long-pore plugging" by cytoplasmic polyamines
34. + channel IRK1
35. Recombinant G-protein beta gamma-subunits activate the muscarinic-gated atrial potassium channel
36. Membrane current through adenosine-triphosphate-regulated potassium channels in guinea-pig ventricular cells
37. ATP-sensitive potassium channel modulation of the guinea pig ventricular action potential and contraction
38. Primary structure and functional expression of a mouse inward rectifier potassium channel
39. +-channel proteins
40. KATP. An inward rectifier subunit plus the sulfonylurea receptor
41. + channel with a novel structure
42. Proton block and voltage gating are potassium-dependent in the cardiac leak channel Kcnk3
43. Mechanisms and management of proarrhythmia
44. The long QT syndrome
45. La tachycardie ventriculaire a deaux foyers opposes variables
46. The electrophysiological mechanism of ventricular arrhythmias in the long QT syndrome
47. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome
48. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias
49. Molecular basis of the long-QT syndrome associated with deafness
50. Ks function
51. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome
52. Multiple mechanisms in the long QT syndrome: Current knowledge, gaps, and future directions
53. HERG channel dysfunction in human long QT syndrome. Intracellular transport and functional defects
54. + channel dysfunction in an inherited cardiac arrhythmia
55. Novel mechanism of HERG current suppression in LQT2: Shift in voltage dependence of HERG inactivation
56. Long QT syndrome-associated mutations in the Per-Arnt-Sim (PAS) domain of HERG potassium channels accelerate channel deactivation
57. Dominant-negative KVLQT1 mutations underlie the LQT1 form of long QT syndrome
58. + channel mutations found in inherited cardiac arrhythmias
59. + channel mutations in Romano-Ward, and Jervell and Lange-Nielsen inherited cardiac arrhythmias
60. Spectrum of mutations in long-QT syndrome genes KVLQT1, HERG, SCN5A, KCNE1, and KCNE2
61. A novel mutation in the potassium channel gene KVLQT1 causes the Jervell and Lange-Nielsen cardioauditory syndrome
62. KCNE1 mutations cause Jervell and Lange-Nielsen syndrome
63. Inner ear defects induced by null mutation of the isk gene
64. Suppression of lethal ischemic ventricular arrhythmias by the class III agent E-4031 in a canine model of previous myocardial infarction
65. Cardiac electrophysiologic and antiarrhythmic actions of two long-acting spirobenzopyran piperidine class III agents, L-702,958 and L-706,000 [MK-499]
66. + channel; open channel block by methanesulfonanilides
67. Trapping of a methanesulfonanilide by closure of the HERG potassium channel activation gate
68. + channels
69. +]o, and C-type inactivation
70. + current in ventricular myocytes of the guinea pig type: Theoretical formulation and their role in repolarization